1. |
DAFF S. NO synthase: structures and mechanisms [J] . Nitric Oxide, 2010, 23(1): 1-11.
|
2. |
ZHANG Y H, CASADEI B. Sub-cellular targeting of constitutive NOS in health and disease [J] . J Mol Cell Cardiol, 2012, 52(2): 341-350.
|
3. |
F RSTERMANN U, SESSA W C. Nitric oxide synthases: regulation and function [J] . Eur Heart J, 2012, 33(7): 829-837, 37a-37d.
|
4. |
MATTILA J T, THOMAS A C. Nitric oxide synthase: non-canonical expression patterns [J] . Front Immunology, 2014, 5: 478.
|
5. |
XIA N, FORSTERMANN U, LI H. Resveratrol and endothelial nitric oxide [J] . Molecules, 2014, 19(10): 16102-16121.
|
6. |
ANDRADE F A, RESTINI C B, GRANDO M D, et al. Vascular relaxation induced by C-type natriuretic peptide involves the Ca2+/NO-synthase/NO pathway [J] . PLoS One, 2014, 9(5): e95446.
|
7. |
BHARATH L P, MUELLER R, LI Y, et al. Impairment of autophagy in endothelial cells prevents shear-stress-induced increases in nitric oxide bioavailability [J] . Can J Physiol Pharmacol, 2014, 92(7): 605-612.
|
8. |
FLEMING I. Molecular mechanisms underlying the activation of eNOS [J] . Pflugers Arch, 2010, 459(6): 793-806.
|
9. |
TIAN X L, LI Y. Endothelial cell senescence and age-relatedvascular diseases [J] . J Genet Genomics, 2014, 41(9): 485-495.
|
10. |
LI H, FORSTERMANN U. Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease [J] . Curr Opin Pharmacol, 2013, 13(2): 161-167.
|
11. |
LI H, HORKE S, FORSTERMANN U. Vascular oxidative stress, nitric oxide and atherosclerosis [J] . Atherosclerosis, 2014, 237(1): 208-219.
|
12. |
CHEN C A, WANG T Y, VARADHARAJ S, et al. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function [J] . Nature, 2010, 468(7327): 1115-1118.
|
13. |
OHTANI K, VLACHOJANNIS G J, KOYANAGI M, et al. Epigenetic regulation of endothelial lineage committed genes in pro-ngiogenic hematopoietic and endothelial progenitor cells [J] . Circ Res, 2011, 109(11): 1219-1229.
|
14. |
BARROSO M, ROCHA M S, ESSE R, et al. Cellular hypomethylation is associated with impaired nitric oxide production by cultured human endothelial cells [J] . Amino Acids, 2012, 42(5): 1903-1911.
|
15. |
KHEIRANDISH-GOZAL L, KHALYFA A, GOZAL D, et al. Endothelial dysfunction in children with obstructive sleep apnea is associated with epigenetic changes in the eNOS gene [J] . Chest, 2013, 143(4): 971-977.
|
16. |
KRAUSE B J, COSTELLO P M, MUNOZ-URRUTIA E, et al. Role of DNA methyltransferase 1 on the altered eNOS expression in human umbilical endothelium from intrauterine growth restricted fetuses [J] . Epigenetics-Us, 2013, 8(9): 944-952.
|
17. |
GODFREY K M, SHEPPARD A, GLUCKMAN P D, et al. Epigenetic gene promoter methylation at birth is associated with child's later adiposity [J] . Diabetes, 2011, 60(5): 1528-1534.
|
18. |
HARVEY N C, LILLYCROP K A, GARRATT E, et al. Evaluation of methylation status of the eNOS promoter at birth in relation to childhood bone mineral content [J] . Calcified Tissue Int, 2012, 90(2): 120-127.
|
19. |
XU X F, MA X L, SHEN Z, et al. Epigenetic regulation of the endothelial nitric oxide synthase gene in persistent pulmonary hypertension of the newborn rat [J] . J Hypertens, 2010, 28(11): 2227-2235.
|
20. |
WON K J, JUNG S H, JUNG S H, et al. DJ-1/park7 modulates vasorelaxation and blood pressure via epigenetic modification of endothelial nitric oxide synthase [J] . Cardiovasc Res, 2014, 101(3): 473-481.
|
21. |
ZHANG Y G, JIA Q Y, HE Q, et al. The Glu298Asp polymorphism in the NOS3 gene and the risk of prostate cancer [J] . Tumor Biol, 2014, 35(5): 4735-4739.
|
22. |
BRANKOVIC A, BRAJUSKOVIC G, NIKOLIC Z, et al. Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population [J] . Int J Exp Pathol, 2013, 94(6): 355-361.
|
23. |
ALPOIM P N, GOMES K B, PINHEIRO M D, et al. Polymorphisms in endothelial nitric oxide synthase gene in early and late severe preeclampsia [J] . Nitric Oxide, 2014, 42: 19-23.
|
24. |
CHEN Y, WANG D, ZHOU M, et al. Polymorphisms of the endothelial nitric oxide synthase gene in preeclampsia in a Han Chinese population [J] . Gynecol Obstet Invest, 2014, 77(3): 150-155.
|
25. |
EROZ R, BAHADIR A, DIKICI S, et al. Association of endothelial nitric oxide synthase gene polymorphisms (894G/T, -786T/C, G10T) and clinical findings in patients with migraine [J] . Neuromolecular Medicine, 2014, 16(3): 587-593.
|
26. |
DELLAMEA B S, PINTO L C, LEITAO C B, et al. Endothelial nitric oxide synthase gene polymorphisms and risk of diabetic nephropathy: a systematic review and meta-analysis [J] . BMC Med Genet, 2014, 15: 9.
|
27. |
KALLEL A, SBAI M H, SEDIRI Y, et al. Polymorphisms of the NOS3 gene and risk of myocardial infarction in the Tunisian population [J] . Cytokine, 2013, 64(3): 646-651.
|
28. |
JEMAA R, KALLEL A, SEDIRI Y, et al. Association between-786TC polymorphism in the endothelial nitric oxide synthase gene and hypertension in the Tunisian population [J] . Exp Mol Pathol, 2011, 90(2): 210-214.
|
29. |
RISBANO M G, GLADWIN M T. Therapeutics targeting of dysregulated redox equilibrium and endothelial dysfunction [M] // HUMBERT N, EVGENOV O V, STASCH J-P. Pharmacotherapy of pulmonary hypertension. Berlin Heidelberg: Springer, 2013: 315-349.
|
30. |
ROCHETTE L, LORIN J, ZELLER M, et al. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? [J] . Pharmacology & Therapeutics, 2013, 140(3): 239-527.
|